Pharmaceutical Packaging Market worth $251.6 billion by 2034 - Exclusive Report by The Research Insights
Market Overview and Growth Trajectory:
Pharmaceutical Packaging Market Growth: According to an exhaustive report by The Research Insights, the Pharmaceutical Packaging Market is experiencing significant growth, driven by the increasing focus on environmental sustainability is transforming various industries including the pharmaceutical packaging market. Because consumers along with governmental bodies and healthcare providers prioritize sustainable practices more than ever before they now seek packaging solutions that serve environmental health in addition to their functional purpose. Biodegradable films along with recyclable blister packs and paper-based secondary packaging solutions together with refillable container systems are becoming more popular. The pharmaceutical packaging market valued at US$ 139.2 billion in 2024, is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.1% during 2025–2034.
For More Information and To Stay Updated on The Latest Developments in The Pharmaceutical Packaging Market, Download The Sample Pages: https://www.theresearchinsights.com/request_sample?id=10035
Escalating the Role of Packaging in Modern Healthcare: The smart healthcare industry's constant evolution has positioned patient safety and drug integrity at the forefront while recognizing packaging as an essential element in fulfilling this mission. The pharmaceutical packaging market adapts to urgent demands for protection against medication contamination, tampering risks and human mistakes. International health authorities and governments have enforced strict regulatory measures aimed at protecting pharmaceutical supply chains. From the U.S. FDA's Drug Supply Chain Security Act to Europe's Falsified Medicines Directive, the message is clear: Product packaging needs to perform beyond containment functions by verifying product authenticity and safeguarding user safety and correct usage. Manufacturers are swiftly incorporating tamper-evident seals together with anti-counterfeit packaging and child-resistant features into their packaging production lines. Healthcare providers demand packaging solutions that reduce risks when medications are dispensed and administered. Accurate dosing blister packs and contamination-reducing prefilled syringes along with real-time product information smart labels are now more prevalent. The pharmaceutical packaging market growth that focuses on security and usability so drugs reach patients safely and maintain effectiveness.
E-commerce Boom Redefines Expectations in the Pharmaceutical Packaging Market: The growth of e-commerce and direct-to-patient healthcare models transforms medicine delivery and creates new requirements for pharmaceutical packaging market. The expanding use of online pharmacies for delivering prescriptions to patients' doorsteps means packaging now functions as an essential component of the healthcare experience. Modern consumers demand identical convenience and security standards for healthcare deliveries compared to their expectations from any online transaction. But pharmaceuticals come with unique challenges: Due to their temperature sensitivity and the need for tamper-proof protection pharmaceuticals must reach their destination intact and punctually. The pharmaceutical packaging market size is rapidly developing to fulfil stringent requirements of the sector. Insulated mailers and smart packaging solutions that monitor temperature in real-time have gained significant popularity because biologics, vaccines, and specialty drugs demand strict temperature control. The pharmaceutical packaging market needs to accelerate innovation at unprecedented rates to adapt to the demands of this new reality.
Stay Updated on The Latest Pharmaceutical Packaging Market Trends: https://www.theresearchinsights.com/request_sample?id=10035
Diverse Drug Delivery Formats Shaping the Future of the Pharmaceutical Packaging Market: Modern therapeutic advances have resulted in various drug delivery formats which create specialized packaging requirements and potential opportunities for pharmaceutical packaging market. The field of ophthalmic drug delivery requires sterile packaging that delivers exact doses through single-use droppers and preservative-free multi-dose systems to protect patients from microbial contamination. Advanced packaging formats like prefilled syringes, vials, and ampoules with tamper-evident seals and temperature-resistant properties maintain drug integrity during storage and transport for injectable and IV drugs used in biologics and oncology treatments. The increasing use of nasal drug delivery for local and systemic treatments, such as vaccines and emergency medications demands the creation of unit-dose or metered-dose spray packaging which supports both easy administration and patient adherence. Effective wound care packaging requires both sterile conditions and easy access which is achieved by medical-grade pouches along with barrier films and reclosable packs for clean repeated usage. The field of pulmonary drug delivery for respiratory conditions is advancing inhaler packaging and dosing systems that guarantee precise administration and enhance patient adherence through innovative designs.
Geographical Insights: The pharmaceutical packaging market is primarily dominated by North America which produces 39% of total global revenue. The region's advanced healthcare infrastructure combined with substantial investments in drug development and the establishment of major pharmaceutical companies drives its market dominance. The European region stands as the second-largest pharmaceutical packaging market with Germany, the United Kingdom, and Italy stand as major contributors to this market due to their solid regulatory systems combined with their strong emphasis on research and development. The Asia-Pacific market stands as the third-largest region in terms of market share which amounts to about 19%. The fast-paced growth of the pharmaceutical industry results from improved healthcare knowledge among populations combined with higher disposable incomes and major investments in pharmaceutical production facilities particularly located in China and India.
Pharmaceutical Packaging Market Segmentation and Geographical Insights:
Based on material, the market is divided into plastic, glass, paper & paperboard, metal and others. The plastic segment held the largest share of the pharmaceutical packaging market in 2024.
Based on packaging format, the market is divided into bottles, vials & ampoules, blister packs, syringes, bags & pouches, sachets & stick packs, cartridges, boxes & cartons and other packaging formats. The bottles segment held the largest share of the pharmaceutical packaging market in 2024.
Based on drug delivery, the market is divided into ophthalmic, injectable, iv drugs, nasal, wound care, pulmonary, oral and others (topical and transdermal treatments). The oral segment accounted for a larger share of the pharmaceutical packaging market in 2024.
Based on end-use, the market is divided into pharma manufacturing, contract packaging, retail pharmacy and institutional pharmacy. The pharma manufacturing segment accounted for a larger share of the pharmaceutical packaging market in 2024.
The pharmaceutical packaging market is segmented into five major regions: North America, Europe, Asia Pacific, Central & South America and Middle East & Africa.
Purchase Premium Copy of Global Pharmaceutical Packaging Market Size and Growth Report (2025-2034) at: https://www.theresearchinsights.com/license?id=10035
Key Players and Competitive Landscape:
The Pharmaceutical Packaging Market is characterized by the presence of several major players, including:
Gerresheimer AG
Schott AG
Owens Illinois, Inc.
Amcor plc
Becton, Dickinson, and Company
AptarGroup, Inc.
West Pharmaceutical Services, Inc.
Ardagh Group S.A.
Smurfit WestRock
Comar, LLC
CCL Industries, Inc.
Vetter Pharma International
SGD Pharma
Bormioli Pharma S.p.A.
Klöckner Pentaplast
These companies are adopting strategies such as new product launches, joint ventures, and geographical expansion to maintain their competitive edge in the market.
For Region-Specific Market Data, Check Out Brief Sample Pages: https://www.theresearchinsights.com/request_sample?id=10035
Pharmaceutical Packaging Market Recent Developments and Innovations:
In April 2025, Gerresheimer AG collaborated with Injecto and launched their silicone-oil- and PFAS-free syringe systems which are made from glass and cyclic olefin polymer (COP). PFAS-free syringe systems can be used for ophthalmic applications and sensitive biologics.
In January 2025, Schott AG launched next generation polymer syringe system which provides tamper evidence at individual syringe level. The integrated label concept, developed with Schreiner MediPharm, offers reliable first-opening indication, oxygen and light protection, and can include an RFID chip for accurate drug traceability and inventory management.
In October 2024, Bormioli Pharma S.p.A. partners with Chiesi Group for providing their first pharma primary packaging in carbon capture PET bottles. Carbon Capture PET bottles provide a 21.9% decrease in kg of CO2 eq compared to traditional PET.
Conclusion:
The pharmaceutical packaging market size is experiencing major changes as global healthcare trends and regulatory pressures combine with growing complexity in drug formulations. The rising popularity of e-commerce and direct-to-patient models together with biologics development requires packaging solutions that maintain safety standards while providing temperature management and supply chain traceability. The movement toward sustainable packaging solutions that support global circular economy objectives drives research into biodegradable, recyclable and refillable materials development. The variety of drug delivery methods including injectables and IV medications together with pulmonary and nasal routes leads to a need for specialized packaging solutions to match different dosage types. The pharmaceutical industry prioritizes patient safety and compliance which leads to the adoption of smart labels, prefilled devices and child-resistant technologies as standard features.
Need A Diverse Region or Sector? Customize Research to Suit Your Requirement: https://www.theresearchinsights.com/Ask_For_Customization?id=10035
The report from The Research Insights, therefore, provides several stakeholders—including raw material suppliers, contract pharma manufacturers, and end users —with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities.
With projected growth to US$ 251.6 billion by 2034, the Pharmaceutical Packaging Market represents a significant opportunity for raw material suppliers, packaging convertors, end-users, investors, industry stakeholders, and others. By staying abreast of market trends, embracing innovation, and focusing on quality and performance, companies can position themselves for success in this dynamic and evolving market landscape.
Related Report Titles:
Pharmaceutical Packaging Equipment Market Size, Share & Trends Analysis Report
Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report
Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends
Vials And Ampoules Market Size, Share & Trends Analysis Report
Small Volume Parenteral Market Size, Share & Trends Analysis Report
About Us:
The Research Insights provides thoroughly conducted research which is backed up by real-time statistics and data. Our experts are eager to help you with any information required under the sun. The key to our success is keeping abreast with the markets, industries, and ever-changing consumer trends that matter. Our market research professionals have in-depth knowledge and expertise across various domains that includes IT and Telecom, Emerging Technologies, Consumer Offerings, Manufacturing and Others. We are committed to reviewing the scope and procedure of the research studies that you select and provide you with an accurate guidance in order to assist you in taking the correct business decisions.
Contact Us:If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Kaushik RoyE-mail: sales@theresearchinsights.comPhone: +1 312-313-8080Website: https://www.theresearchinsights.com/
Logo: https://mma.prnewswire.com/media/2684869/The_Research_Insights_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/pharmaceutical-packaging-market-worth-251-6-billion-by-2034---exclusive-report-by-the-research-insights-302453600.html
SOURCE The Research Insights
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Bank of America says buy these 10 ultra-cheap stocks primed to rebound
Bank of America predicts that large-cap stock dominance of the stock market could soon end. If the US economy enters a recovery phase alongside rate cuts, beaten-down stocks could surge. BofA recently shared top stock picks with low valuations that could be primed for a rebound. Bank of America says large-cap dominance inoof the stock market may soon be over. The bank's economic regime indicator shows the US economy hovering between downturn and recovery phases. If it starts to enter the latter alongside Fed rate cuts and improving earnings, smaller and cheaper stocks in the S&P 500 should start to outperform the largest companies, the bank said in a recent client note. "Recoveries saw 2x PE expansion for the Not-So-Nifty 450 as the Nifty 50, and the Smallest 50 enjoyed 12ppt ann. alpha," said Savita Subramanian, the bank's head of US equity and quantitative strategy, said in the note. "History would suggest there is more to go in cap-weighted dominance. But if the Fed's next move is a rate cut, and if the Regime indicator is shifting to a Recovery, we think the run may be closer to done." As a way to invest in the potential trend, Subramanian and her team highlighted stocks with 12-month forward price-to-earnings ratios below the S&P 500's median; those with high beta, or volatility relative to the index; and those with market caps below the S&P 500's median. All of the stocks have a "Buy" rating from BofA. We've taken the 10 cheapest stocks from the list and compiled them in descending order according to their forward P/E ratios. Eastman Chemical Company Ticker: EMN Forward P/E: 9.3 Beta: 1.2 Market cap: $8.3 billion Sector: Materials Halliburton Company Ticker: HAL Forward P/E: 9.1 Beta: 1.1 Market cap: $19 billion Sector: Energy First Solar Ticker: FSLR Forward P/E: 9 Beta: 1.3 Market cap: $18.7 billion Sector: Information Technology Healthpeak Properties Ticker: DOC Forward P/E: 9 Beta: 1 Market cap: $11.7 billion Sector: Real Estate Aptiv Ticker: APTV Forward P/E: 8.9 Beta: 1.3 Market cap: $14.9 billion Sector: Consumer Discretionary Synchrony Financial Ticker: SYF Forward P/E: 8.4 Beta: 1.3 Market cap: $25.9 billion Sector: Financials Delta Air Lines Ticker: DAL Forward P/E: 8.4 Beta: 1.4 Market cap: $34.7 billion Sector: Industrials Host Hotels & Resorts Ticker: HST Forward P/E: 8.1 Beta: 1.2 Market cap: $21 billion Sector: Real Estate Devon Energy Ticker: DVN Forward P/E: 8.0 Beta: 1.1 Market cap: $21 billion Sector: Energy United Airlines Ticker: UAL Forward P/E: 7.7 Beta: 1.3 Market cap: $28.5 billion Sector: Industrials Read the original article on Business Insider Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
42 minutes ago
- Yahoo
Nat-Gas Prices Plunge on Cooler Weather Forecasts and Higher US Production
September Nymex natural gas (NGU25) on Tuesday closed down -0.124 (-4.29%). Sep nat-gas prices on Tuesday plunged to a 9.25-month nearest-futures low and settled sharply lower on forecasts for cooler US weather and the outlook for higher US nat-gas production. Forecaster Atmospheric G2 said Tuesday that forecasts shifted cooler across the eastern two-thirds of the US and Southwest for August 24-29, which will curb nat-gas demand from electricity providers to power air conditioning. More News from Barchart Nat-Gas Prices Settle Lower on Forecasts for Cooler US Temps Crude Prices Gain on Doubts About an Early End to Russian-Ukrainian War Why Oneok's (OKE) Post-Earnings Meltdown May Spell Opportunity for Contrarian Options Traders Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Ramped-up US nat-gas production is another bearish factor for prices. Last Tuesday, the EIA raised its forecast for 2025 US nat-gas production by +0.5% to 106.44 bcf/day from July's estimate of 105.9 bcf/day. The EIA raised its forecast for 2026 US nat-gas production by +0.7% to 106.09 from July's 105.4 bcf/day forecast. US nat-gas production is currently near a record high, with active US nat-gas rigs recently posting a 2-year high. US (lower-48) dry gas production on Tuesday was 108.4 bcf/day (+5.7% y/y), according to BNEF. Lower-48 state gas demand on Tuesday was 79.8 bcf/day (+2.7% y/y), according to BNEF. Estimated LNG net flows to US LNG export terminals on Tuesday were 14.8 bcf/day (-6.1% w/w), according to BNEF. In a bearish factor, the Edison Electric Institute reported last Wednesday that US (lower-48) electricity output in the week ended August 9 fell -1.9% y/y to 93,293 GWh (gigawatt hours), although US electricity output in the 52-week period ending August 9 rose +2.6% y/y to 4,257,529 GWh. Last Thursday's weekly EIA report was slightly bearish for nat-gas prices since nat-gas inventories for the week ended August 1 rose +56 bcf, slightly above the consensus of +54 bcf and well above the 5-year weekly average of +33 bcf. As of August 8, nat-gas inventories were down -2.4% y/y, but were +6.6% above their 5-year seasonal average, signaling adequate nat-gas supplies. As of August 16, gas storage in Europe was 74% full, compared to the 5-year seasonal average of 81% full for this time of year. Baker Hughes reported last Friday that the number of active US nat-gas drilling rigs in the week ending August 15 fell by -1 to 122 rigs, slipping a bit farther from the 2-year high of 124 rigs posted on August 1. In the past year, the number of gas rigs has risen from the 4-year low of 94 rigs reported in September 2024. On the date of publication, Rich Asplund did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
42 minutes ago
- Yahoo
Crude Prices Slip on Prospects to End the War in Ukraine
September WTI crude oil (CLU25) on Tuesday closed down -1.07 (-1.69%), and September RBOB gasoline (RBU25) closed down -0.0097 (-0.46%). Crude oil prices retreated on Tuesday on signs of progress in Ukraine peace talks, which could pave the way for fewer restrictions on Russian crude exports. Tuesday's stronger dollar also weighed on crude prices. More News from Barchart Nat-Gas Prices Settle Lower on Forecasts for Cooler US Temps Why Oneok's (OKE) Post-Earnings Meltdown May Spell Opportunity for Contrarian Options Traders Crude Prices Gain on Doubts About an Early End to Russian-Ukrainian War Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! Signs of progress in peace talks over the Ukraine war are weighing on crude prices. Ukrainian President Zelenskiy said late Monday that he came away with a commitment from President Trump to join security guarantees for any peace deal and reserve discussion on territorial swaps with Russia for later. President Trump is pushing for a summit between Presidents Putin and Zelenskiy soon. Any resolution to the Russian-Ukrainian war could be bearish for crude prices, as an end to the war could mean allowing Russian crude to trade freely and could lead to an end to sanctions on Russian energy exports. Concern about higher OPEC production is weighing on crude prices after OPEC+ on August 2 endorsed an additional 547,000 bpd increase in its crude production for September 1. OPEC+ is boosting output to reverse the 2-year-long production cut, gradually restoring a total of 2.2 million bpd of production by September 2026. OPEC+ has 1.66 million bpd of supplies that are currently due to remain offline until late 2026. OPEC July crude production fell by -20,000 bpd to 28.31 million bpd. A decline in crude oil held worldwide on tankers is bullish for oil prices. Vortexa reported Monday that crude oil stored on tankers that have been stationary for at least seven days fell by -12% w/w to 82.49 million bbl in the week ended August 15. The consensus is that Wednesday's weekly EIA crude inventories will fall by -850,000 bbl, and gasoline supplies will decline by -325,000 bbl. Last Wednesday's weekly EIA report showed that US crude oil inventories rose +3.04 million bbls to a 2-month high in the week ended August 8. The weekly EIA report showed that (1) US crude oil inventories as of August 8 were -5.1% below the seasonal 5-year average, (2) gasoline inventories were +0.25% above the seasonal 5-year average, and (3) distillate inventories were -15.45% below the 5-year seasonal average. US crude oil production in the week ending August 8 rose by +0.3% y/y to 13.327 million bpd, modestly below the record high of 13.631 million bpd posted in the week of 12/6/2024. Baker Hughes reported last Friday that the number of active US oil rigs in the week ending August 15 was unchanged at 411 rigs, just slightly above the 3.75-year low of 410 rigs from August 1. Over the past 2.5 years, the number of US oil rigs has fallen sharply from the 5.25-year high of 627 rigs reported in December 2022. On the date of publication, Rich Asplund did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
